<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01030991</url>
  </required_header>
  <id_info>
    <org_study_id>AHA 0835488N</org_study_id>
    <nct_id>NCT01030991</nct_id>
  </id_info>
  <brief_title>Classification of Heart Failure With Preserved Ejection Fraction</brief_title>
  <official_title>Etiologic, Pathophysiologic, and Genetic Classification of Heart Failure With Preserved Ejection Fraction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to create a classification system for the heterogenous disorder
      of heart failure with preserved ejection fraction (HFpEF).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with HFpEF are a heterogeneous group with varying etiology and pathophysiology,
      which may play a large role in the difficulty in managing these patients and enrolling them
      in clinical trials. A major advance in the care of patients with HFpEF would be a
      classification system based on etiology, pathophysiology, and/or genetic factors as well as
      machine learning analyses. The ultimate goal of this study is to demonstrate that it is
      possible to better classify patients with HFpEF based on etiologic, pathophysiologic, and
      genetic differences between patients. If successful, this study could lead to: (1) novel risk
      estimation in patients with HFpEF and (2) more fruitful clinical trials based on targeting
      specific subsets of HFpEF.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Heart failure hospitalization</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular hospitalization</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality - all cause and cardiovascular</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exercise capacity (peak VO2)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Heart Failure With Preserved Ejection Fraction</condition>
  <condition>Diastolic Heart Failure</condition>
  <arm_group>
    <arm_group_label>HFpEF</arm_group_label>
    <description>HFpEF cohort (observational study)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with signs or symptoms of heart failure with left ventricular ejection
        fraction &gt; 50% are eligible for the study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 21 years

          -  Signs or symptoms of congestive heart failure

          -  Left ventricular ejection fraction &gt; 50%

        Exclusion Criteria:

          -  Severe valvular heart disease

          -  History of cardiac transplantation

          -  Prior history of heart failure associated with left ventricular ejection fraction &lt;
             35%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjiv J Shah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University Feinberg School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University Feinberg School of Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.hfpef.northwestern.edu</url>
    <description>Northwestern University Heart Failure with Preserved Ejection Fraction (HFpEF) Program</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2009</study_first_submitted>
  <study_first_submitted_qc>December 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2009</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Sanjiv Shah</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Ejection fraction</keyword>
  <keyword>Diastolic heart failure</keyword>
  <keyword>Diastolic dysfunction</keyword>
  <keyword>Ventricular-arterial coupling</keyword>
  <keyword>Exercise testing</keyword>
  <keyword>Echocardiography</keyword>
  <keyword>Tissue Doppler imaging</keyword>
  <keyword>Arterial tonometry</keyword>
  <keyword>Genetics</keyword>
  <keyword>Epidemiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Diastolic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

